IR News

Jan. 29, 2020Print(PDF/102KB)Sustainability

Donations for the Prevention of Pneumonia Caused by the New Coronavirus in China

We at Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) would like to express our heartfelt sympathy to those who have been affected by pneumonia caused by the new coronavirus. We sincerely hope that this infection will be contained as soon as possible.

Sumitomo Dainippon Pharma announced today that Sumitomo Pharmaceuticals (Suzhou) Co., Ltd., its subsidiary in China, has decided to donate RMB 1 million (approximately JPY 15 million) to the Chinese Red Cross Foundation for the prevention and containment of pneumonia caused by infection with the new coronavirus.

This donation will be purposed as funds to purchase medical protectors, such as protective clothing, masks, and disinfectants, and treatment equipment, in response to demand from healthcare professionals in the field, so that they can provide treatment safely at hospitals in Wuhan, China. Sumitomo Dainippon Pharma and Sumitomo Pharma (Suzhou) strongly hope that the disease will come under control soon and that the safety of the medical professionals on the front line will be assured.